Next Article in Journal
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
Next Article in Special Issue
Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
Previous Article in Journal
Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts
Previous Article in Special Issue
Dose-Dependent Solubility–Permeability Interplay for Poorly Soluble Drugs under Non-Sink Conditions
 
 
Article

Article Versions Notes

Pharmaceutics 2021, 13(3), 383; https://doi.org/10.3390/pharmaceutics13030383
Action Date Notes Link
article xml file uploaded 13 March 2021 10:05 CET Original file -
article xml uploaded. 13 March 2021 10:05 CET Update -
article pdf uploaded. 13 March 2021 10:05 CET Version of Record https://www.mdpi.com/1999-4923/13/3/383/pdf-vor
article html file updated 13 March 2021 10:06 CET Original file -
article xml file uploaded 15 March 2021 03:16 CET Update -
article xml uploaded. 15 March 2021 03:16 CET Update -
article pdf uploaded. 15 March 2021 03:16 CET Updated version of record https://www.mdpi.com/1999-4923/13/3/383/pdf-vor
article html file updated 15 March 2021 03:17 CET Update -
article xml file uploaded 25 March 2021 09:43 CET Update -
article xml uploaded. 25 March 2021 09:43 CET Update https://www.mdpi.com/1999-4923/13/3/383/xml
article pdf uploaded. 25 March 2021 09:43 CET Updated version of record https://www.mdpi.com/1999-4923/13/3/383/pdf
article html file updated 25 March 2021 09:46 CET Update -
article html file updated 25 July 2022 07:30 CEST Update https://www.mdpi.com/1999-4923/13/3/383/html
Back to TopTop